Skip to main content
. 2026 Jan 18;33(1):57. doi: 10.3390/curroncol33010057
AUC Area under the curve
BOR Best overall response
CPS Combined positive core
CR Complete response
DCR Disease control rate
irAE Immune-related adverse event
mOS Median overall survival
mPFS Median progression-free survival
NCCN National Comprehensive Cancer Network
ORR Overall response rate
OS Overall survival
PD Progression disease
PFS Progression-free survival
PR Partial response
PS Performance status
R/M SCCHN Recurrent or metastatic squamous cell carcinoma of the head and neck
SD Stable disease